Clinical trials are underway for a neural implant to monitor brain pressure in those living with hydrocephalus.

The condition causes fluid to build up in the brain which, if untreated, can be fatal.

Patients can be born with hydrocephalus or develop it later in life.

It is typically treated with a small tube, called a shunt, implanted under the skin which drains fluid from the brain into the stomach.

However, shunts had a 50 percent chance of failure in the first two years.

To tackle this, researchers at the Auckland Bioengineering Institute and Kitea Health developed an implant to measure pressure in the brain using an external, wireless wand.

The implant is only two by three millimetres, and weighs 0.3 of a gram.

Clinical trials in adults are about 50 percent complete, and trials on children have begun.

It is a world first, the smallest brain implant ever developed, as well as the first implantable medical device developed in New Zealand.

  • Dave@lemmy.nzOPM
    link
    fedilink
    arrow-up
    0
    ·
    10 days ago

    Yeah scary stuff, and it makes you wonder if all that misdiagnosis is impacting on research by throwing out the results.

    • liv@lemmy.nz
      link
      fedilink
      arrow-up
      0
      ·
      9 days ago

      Didn’t think of that - it might be, since formal dementia diagnoses are symptom based not biomarker based.

      This is what’s happening at the moment with long covid studies to some extent because it’s not just one illness, it’s a raft of illnesses that have been caused by the same virus.